A study demonstrated that treatment with genistein in SW1116 colon cancer cells reactivated the Wnt5a gene, which acts as an antagonist to the Wnt signaling pathway, frequently overactivated in colon cancer. This evidence concerns the gene WNT5A and malignant colon neoplasm.